Literature DB >> 25572405

Epigenetic mechanisms in heart development and disease.

Shannalee R Martinez1, Maresha S Gay1, Lubo Zhang2.   

Abstract

Suboptimal intrauterine development has been linked to predisposition to cardiovascular disease in adulthood, a concept termed 'developmental origins of health and disease'. Although the exact mechanisms underlying this developmental programming are unknown, a growing body of evidence supports the involvement of epigenetic regulation. Epigenetic mechanisms such as DNA methylation, histone modifications and micro-RNA confer added levels of gene regulation without altering DNA sequences. These modifications are relatively stable signals, offering possible insight into the mechanisms underlying developmental origins of health and disease. This review will discuss the role of epigenetic mechanisms in heart development as well as aberrant epigenetic regulation contributing to cardiovascular disease. Additionally, we will address recent advances targeting epigenetic mechanisms as potential therapeutic approaches to cardiovascular disease.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25572405      PMCID: PMC4492921          DOI: 10.1016/j.drudis.2014.12.018

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  150 in total

1.  Crystal structure of the nucleosome core particle at 2.8 A resolution.

Authors:  K Luger; A W Mäder; R K Richmond; D F Sargent; T J Richmond
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

2.  HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats.

Authors:  Jeffrey P Cardinale; Srinivas Sriramula; Romain Pariaut; Anuradha Guggilam; Nithya Mariappan; Carrie M Elks; Joseph Francis
Journal:  Hypertension       Date:  2010-08-02       Impact factor: 10.190

3.  Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy.

Authors:  Mamoru Satoh; Yoshitaka Minami; Yuji Takahashi; Tsuyoshi Tabuchi; Motoyuki Nakamura
Journal:  J Card Fail       Date:  2010-03-03       Impact factor: 5.712

Review 4.  Epigenetics and cardiovascular development.

Authors:  Ching-Pin Chang; Benoit G Bruneau
Journal:  Annu Rev Physiol       Date:  2011-10-24       Impact factor: 19.318

5.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

6.  Clinical applications of miRNAs in cardiac remodeling and heart failure.

Authors:  Veli K Topkara; Douglas L Mann
Journal:  Per Med       Date:  2010-09-01       Impact factor: 2.512

7.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

8.  DNA hypomethylation and methyltransferase expression in atherosclerotic lesions.

Authors:  Mikko O Hiltunen; Mikko P Turunen; Tomi P Häkkinen; Juha Rutanen; Maria Hedman; Kimmo Mäkinen; Anna-Mari Turunen; Katriina Aalto-Setälä; Seppo Ylä-Herttuala
Journal:  Vasc Med       Date:  2002-02       Impact factor: 3.239

9.  5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.

Authors:  E Martin-Rendon; D Sweeney; F Lu; J Girdlestone; C Navarrete; S M Watt
Journal:  Vox Sang       Date:  2008-06-28       Impact factor: 2.144

10.  DNA methylation of the first exon is tightly linked to transcriptional silencing.

Authors:  Fabienne Brenet; Michelle Moh; Patricia Funk; Erika Feierstein; Agnes J Viale; Nicholas D Socci; Joseph M Scandura
Journal:  PLoS One       Date:  2011-01-18       Impact factor: 3.240

View more
  28 in total

1.  Foetal hypoxia impacts methylome and transcriptome in developmental programming of heart disease.

Authors:  Lei Huang; Xin Chen; Chiranjib Dasgupta; Wanqiu Chen; Rui Song; Charles Wang; Lubo Zhang
Journal:  Cardiovasc Res       Date:  2019-07-01       Impact factor: 10.787

Review 2.  Clinical value of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases.

Authors:  Sébastien Bonnet; Olivier Boucherat; Roxane Paulin; Danchen Wu; Charles C T Hindmarch; Stephen L Archer; Rui Song; Joseph B Moore; Steeve Provencher; Lubo Zhang; Shizuka Uchida
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-04       Impact factor: 4.249

Review 3.  Maternal vitamin D deficiency and developmental origins of health and disease (DOHaD).

Authors:  Folami Y Ideraabdullah; Anthony M Belenchia; Cheryl Susan Rosenfeld; Seth W Kullman; Megan Knuth; Debrata Mahapatra; Michael Bereman; Edward D Levin; Catherine Ann Peterson
Journal:  J Endocrinol       Date:  2019-03-01       Impact factor: 4.286

Review 4.  Glucocorticoids and programming of the microenvironment in heart.

Authors:  Rui Song; Xiang-Qun Hu; Lubo Zhang
Journal:  J Endocrinol       Date:  2019-07-01       Impact factor: 4.286

Review 5.  Kabuki syndrome: review of the clinical features, diagnosis and epigenetic mechanisms.

Authors:  Yi-Rou Wang; Nai-Xin Xu; Jian Wang; Xiu-Min Wang
Journal:  World J Pediatr       Date:  2019-10-05       Impact factor: 2.764

Review 6.  Gestational Hypoxia and Developmental Plasticity.

Authors:  Charles A Ducsay; Ravi Goyal; William J Pearce; Sean Wilson; Xiang-Qun Hu; Lubo Zhang
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 7.  Homeobox gene Meis1 modulates cardiovascular regeneration.

Authors:  Swagatika Paul; Xiaonan Zhang; Jia-Qiang He
Journal:  Semin Cell Dev Biol       Date:  2019-10-14       Impact factor: 7.727

Review 8.  [Research progress on miR-21 in heart diseases].

Authors:  Kun Yang; Xiaosheng Hu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-04-25

9.  Genome-Wide Association Study of Down Syndrome-Associated Atrioventricular Septal Defects.

Authors:  Dhanya Ramachandran; Zhen Zeng; Adam E Locke; Jennifer G Mulle; Lora J H Bean; Tracie C Rosser; Kenneth J Dooley; Clifford L Cua; George T Capone; Roger H Reeves; Cheryl L Maslen; David J Cutler; Eleanor Feingold; Stephanie L Sherman; Michael E Zwick
Journal:  G3 (Bethesda)       Date:  2015-07-20       Impact factor: 3.154

Review 10.  Nutrigenomics, the Microbiome, and Gene-Environment Interactions: New Directions in Cardiovascular Disease Research, Prevention, and Treatment: A Scientific Statement From the American Heart Association.

Authors:  Jane F Ferguson; Hooman Allayee; Robert E Gerszten; Folami Ideraabdullah; Penny M Kris-Etherton; José M Ordovás; Eric B Rimm; Thomas J Wang; Brian J Bennett
Journal:  Circ Cardiovasc Genet       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.